SCPX

Scorpius Holdings, Inc. · AMEX

Sector Health Technology
Industry Pharmaceuticals: Major
Website nighthawkbio.com
Employees(FY) 77
ISIN US42237K5083

Performance

-17.08%

-18.9%

-30.0%

-96.79%

-99.24%

YTD

-99.24%

Profile

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Advanced Technical Analysis

Technical Analysis of SCPX 2024-11-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of SCPX

Stock Rank

Recent News & Updates

2024-11-18 18:30
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model(Globenewswire)
2024-11-14 03:15
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability(Globenewswire)
2024-11-03 18:30
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement(Globenewswire)
2024-10-30 19:30
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually(Globenewswire)
2024-10-22 03:58
Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities(Yahoo Finance)
2024-10-21 20:00
Scorpius Holdings Announces Partnership with U.S. Biotech Company(Globenewswire)
2024-10-01 20:00
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats(Globenewswire)
2024-09-29 20:00
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities(Globenewswire)
2024-09-11 20:00
Scorpius Holdings Commends the U.S. House of Representatives' Passage of the BIOSECURE Act(Globenewswire)
2024-09-08 20:30
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA(Globenewswire)
2024-08-25 20:00
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow(Globenewswire)
2024-08-19 21:15
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024(Yahoo Finance)
2024-08-19 01:08
Scorpius Holdings, Inc. Announces Closing of Public Offering(Yahoo Finance)
2024-08-15 21:50
Scorpius Holdings, Inc. Announces Pricing of Public Offering(Yahoo Finance)
2024-08-09 03:38
Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering(Yahoo Finance)
2024-08-06 09:25
Scorpius Holdings, Inc. Announces Pricing of Public Offering(Yahoo Finance)
2024-08-05 20:45
Scorpius Holdings Weighted-Average Pipeline Surpasses $100 Million in Business Develop Opportunities Across Both Manufacturing Client and Government Sectors(Yahoo Finance)
2024-08-05 20:16
Exclusive: Healthcare Service Provider Scorpius Surpasses $100M In Business Opportunities, Eyes Revenue Boost(Yahoo Finance)
2024-07-29 20:00
Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024(Yahoo Finance)
2024-07-23 20:30
Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter(Yahoo Finance)
2024-07-17 20:30
Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility(Yahoo Finance)
2024-07-17 04:30
Scorpius Holdings Announces Reverse Stock Split(Yahoo Finance)
2024-06-16 20:00
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal(Globenewswire)
2024-06-16 20:00
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal(Yahoo Finance)
2024-06-02 20:00
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing(Globenewswire)
2024-06-02 20:00
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing(Yahoo Finance)
2024-05-28 19:00
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024(Yahoo Finance)
2024-05-28 19:00
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024(Globenewswire)
2024-05-19 20:00
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility(Yahoo Finance)
2024-05-19 20:00
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility(Globenewswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.